−0.376AUD
−52.45 MAUD
18.92 MAUD
620.66 M
About MELODIOL GLOBAL HEALTH LIMITED
Sector
CEO
William Lay
Headquarters
Nedlends
Website
Founded
2015
ISIN
AU0000282840
FIGI
BBG00F0TJVX7
Melodiol Global Health Ltd. engages in the developing, register and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. It operates through the following geographical segments: Europe includes Creso Pharma Switzerland GmbH, Canada includes the operating companies; Mernova Medicinal Inc, Halucenex Life Sciences Inc., Creso Impactive Ltd, United States of America, and Creso Pharma Limited in Australia. The company was founded by Adam Blumenthal, Miri Halperin Wernli and Boaz Wachtel on November 20, 2015 and is headquartered in Nedlends, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ME1 is 0.003 AUD — it has decreased by 25.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MELODIOL GLOBAL HEALTH LIMITED stocks are traded under the ticker ME1.
ME1 stock is 33.33% volatile and has beta coefficient of 1.37. Check out the list of the most volatile stocks — is MELODIOL GLOBAL HEALTH LIMITED there?
Yes, you can track MELODIOL GLOBAL HEALTH LIMITED financials in yearly and quarterly reports right on TradingView.
ME1 stock has fallen by 25.00% compared to the previous week, the month change is a 40.00% fall, over the last year MELODIOL GLOBAL HEALTH LIMITED has showed a 98.64% decrease.
ME1 net income for the last quarter is −24.20 M AUD, while the quarter before that showed −28.25 M AUD of net income which accounts for 14.36% change. Track more MELODIOL GLOBAL HEALTH LIMITED financial stats to get the full picture.
Today MELODIOL GLOBAL HEALTH LIMITED has the market capitalization of 2.02 M, it has increased by 56.42% over the last week.
No, ME1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ME1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MELODIOL GLOBAL HEALTH LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MELODIOL GLOBAL HEALTH LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MELODIOL GLOBAL HEALTH LIMITED stock shows the sell signal. See more of MELODIOL GLOBAL HEALTH LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.